Post sponsored by

Source: United Kingdom – Executive Government & Departments

A study published in mBio looks at Measles-Mumps-Rubella (MMR) antibodies and COVID-19 disease severity.

Dr Simon Clarke, Associate Professor of Cellular Microbiology at the University of Reading, said:

“The authors of this study show that people with higher amounts of antibodies reactive to the mumps virus, had less severe Covid-19 symptoms.  Unfortunately, the authors appear not to have determined the total concentration of antibodies in the blood of these patients, so it might be the case that they just had higher concentrations of all antibodies in their blood, not just those which are reactive to mumps.  This merely demonstrates a correlation, which as always is not evidence of causation.  There is no confirmation that it is the anti-mumps antibodies that is causing the decrease in severity of symptoms.”

‘Analysis of Measles-Mumps-Rubella (MMR) Titers of Recovered COVID-19 Patients’ by Gold et al. was published in mBio on Friday 20 November 2020.

DOI: 10.1128/mBio.02628-20

Declared interests

None received.

MIL OSI United Kingdom